NIDA Notes Articles: Clinical Trials Network

NIDA Notes
Share
NIDA Notes Category Graphic

Vouchers Improve Mothers’ Smoking Abstinence and Newborns’ Weights

April 2012
Pregnant women who received financial incentives to refrain from smoking during late pregnancy were more successful at remaining abstinent and less likely to have babies with low birth weight, according to data from three trials.

NIDA Notes Category Graphic

Alleviation of Posttraumatic Stress Disorder May Improve Addiction Treatment

April 2012
Women with posttraumatic stress disorder (PTSD) who abused drugs responded better to substance abuse treatment after their PTSD symptoms improved, according to a recent study, which also found that reductions in substance abuse did not ease PTSD severity

NIDA Notes Category Graphic

Women and Sex/Gender Differences Research Program

April 2012
NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

NIDA Notes Category Graphic

NIDA Announces Avant-Garde Medication Development Awards

March 2012
Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

NIDA Notes Category Graphic

Incentives Promote Abstinence

December 2010
Explores research findings on the value of motivational incentives to promote and reinforce abstinence from substances of abuse and encourage healthy behaviors.

NIDA Notes Category Graphic

Dr. Kathleen T. Brady Recognized

October 2010
Recognizes the 2010 Distinguished University Professor awardee, Dr. Kathleen T. Brady, who studies co-occurring substance abuse and mental health disorders and their treatment.

NIDA Notes Category Graphic

Dr. Phil Skolnick Now Leads NIDA's Medications Development Efforts

April 2010
Announces the appointment of Dr. Phil Skolnick as NIDA’s director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse.

NIDA Notes Category Graphic

Young Opioid Abusers Benefit From Extended Buprenorphine-Naloxone Treatment

April 2010
Reports on a study investigating the benefits of extended opioid maintenance therapy that included drug counseling and 12 weeks of therapy with buprenorphine and naloxone.

NIDA Notes Category Graphic

Incentives Reduce Stimulant Abuse During Methadone Maintenance

April 2007
Summarizes a study on the use of incentives to encourage abstinence among methadone maintenance patients in outpatient programs.

NIDA Notes Category Graphic

Addiction and Co-Occurring Mental Disorders

February 2007
Presents an overview of the research underway to investigate medication and behavioral therapies for co-occurring disorders.

Mobile Site